HALOZYME THERAPEUTICS, INC. - HALO

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$9.765B
QoQ value delta ($000)
+$1.936B (+24.74%)
Implied price effect (QoQ)
+20.51%
Shares
Total shares
125,360,301
QoQ shares delta
+4,242,714 (+3.5%)
Total shares held by funds (by quarter)

Market chart (HALO)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 677 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
BlackRock, Inc. 1,038,728 13,271,095 0.02%
VANGUARD CAPITAL MANAGEMENT LLC 418,847 5,351,312 0.01%
VANGUARD PORTFOLIO MANAGEMENT LLC 414,753 5,299,008 0.02%
STATE STREET CORP 405,379 5,179,434 0.01%
Invesco Ltd. 248,741 3,177,997 0.02%
MORGAN STANLEY 221,707 2,832,594 0.01%
Boston Partners 216,820 2,773,568 0.19%
BANK OF AMERICA CORP /DE/ 214,503 2,740,561 0.01%
GEODE CAPITAL MANAGEMENT, LLC 197,281 2,519,951 0.01%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 196,539 2,511,050 0.59%
SNYDER CAPITAL MANAGEMENT L P 187,542 2,396,101 3.24%
DIMENSIONAL FUND ADVISORS LP 163,542 2,089,567 0.03%
D. E. Shaw & Co., Inc. 160,021 2,044,479 0.08%
LOS ANGELES CAPITAL MANAGEMENT LLC 151,690 1,938,035 0.56%
ROYAL LONDON ASSET MANAGEMENT LTD 141,732 1,810,815 0.26%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 133,420 1,704,623 0.06%
TWO SIGMA INVESTMENTS, LP 129,402 1,653,285 0.09%
UBS Group AG 116,796 1,492,224 0.01%
FULLER & THALER ASSET MANAGEMENT, INC. 116,700 1,491,004 0.32%
NORGES BANK 116,125 1,483,648 0.01%
FIRST TRUST ADVISORS LP 110,913 1,417,063 0.07%
LSV ASSET MANAGEMENT 110,381 1,410,257 0.2%
ALLIANCEBERNSTEIN L.P. 109,647 1,696,538 0.04%
Stephens Investment Management Group LLC 109,015 1,392,819 1.17%
WELLS FARGO & COMPANY/MN 108,828 1,390,428 0.02%